KB Financial Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$247K Buy
1,673
+47
+3% +$8.5K 0.07% 156
2023
Q2
$355K Sell
1,626
-1,152
-41% -$257K 0.1% 135
2023
Q1
$608K Buy
2,778
+429
+18% +$93.1K 0.18% 71
2022
Q4
$489K Sell
2,349
-320
-12% -$70.3K 0.17% 84
2022
Q3
$583K Buy
2,669
+542
+25% +$123K 0.21% 60
2022
Q2
$446K Sell
2,127
-22
-1% -$4.68K 0.15% 78
2022
Q1
$521K Buy
2,149
+232
+12% +$56.1K 0.14% 77
2021
Q4
$499K Buy
1,917
+401
+26% +$104K 0.14% 76
2021
Q3
$399K Buy
1,516
+103
+7% +$28.2K 0.15% 93
2021
Q2
$349K Buy
1,413
+200
+16% +$42K 0.13% 94
2021
Q1
$236K Buy
+1,213
New +$243K 0.1% 111

Other funds holding RMD

KB Financial Partners's RMD Position: Q3 2023 in Review

KB Financial Partners increased its ResMed (RMD) stake by 2.9% in Q3 2023, buying an estimated $8.5K and bringing the position to 1,673 shares worth $247K. The position accounts for 0.07% of the portfolio, ranked #156.

KB Financial Partners first reported a position in RMD in Q1 2021 and has held it in 11 quarters since. The position peaked at $608K in Q1 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • KB Financial Partners held 1,673 shares of ResMed worth $247K as of Q3 2023.
  • KB Financial Partners bought 47 ResMed shares in Q3 2023, an estimated $8.5K.
  • ResMed made up 0.07% of KB Financial Partners's portfolio in Q3 2023, its #156 holding.
  • KB Financial Partners first reported a position in ResMed in Q1 2021 and has held it in 11 quarters since.
  • KB Financial Partners's ResMed position peaked at $608K in Q1 2023.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.